Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall gadodiamideGadolinium is a heavy metal ion used as a contrast agent to provide a clearer picture of body organs and tissues in magnetic resonance imaging (MRI) and blood vessels in magnetic resonance angiography (MRA). Unfortunately, gadolinium has been linked to several deaths due to a progressive disease known as NSF (nephrogenic systemic fibrosis), or NFD (nephrogenic fibrosing dermopathy).
If someone you love suffered a gadolinium-related death, learn more about your legal options by contacting an attorney today.
Nephrogenic Systemic Fibrosis
NSF was unknown before 1997, and several medical researchers have suggested that its sudden presence in the last 10 years makes it likely that a new agent or examination technique has something to do with its development. More than 170 cases of NSF have been reported worldwide since 1997.
The disease causes fibrosis (thickening and hardening) of skin and connective tissues that can also threaten internal organs such as the heart, brain, spinal cord, diaphragm and liver. There is no consistently successful treatment for NSF, and as it progresses, a person with NSF loses the ability to move freely due to stiffened joints and skin. NSF deaths can occur due to internal organ failure.
Gadolinium, Death and NSF
A study published in 2006 in the journal Nephrology, Dialysis and Transplantation described nine patients with renal failure who had undergone a gadolinium-enhanced MRA and then developed symptoms of NSF within a few weeks. Death due to NSF complications occurred in some of these patients. The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are currently studying the link between gadolinium and death due to NSF.
NSF Symptoms
Contact your medical care provider immediately if you received an MRI or MRA using a gadolinium-based contrast agent and you're experiencing any of the following symptoms, which may indicate the development of NSF:
Gadolinium Lawsuit
Gadolinium-linked NSF deaths have been reported in the United States. A 24-year-old man in Ohio died in 2004 of NSF after receiving the gadolinium-based contrast agent Magnevist as part of an MRI examination for kidney disease. His family is suing the makers of Magnevist for his wrongful death.
If you or a loved one underwent a medical procedure using gadolinium and adverse effects have occurred, consult an attorney to discuss your circumstances and explore your legal options.
The Food and Drug Administration finalized on Friday its earlier action to strengthen the label on certain dyes used for magnetic resonance imaging, or MRI. The dyes will now carry a bold black box to warn of a potentially fatal side effect in some kid...